RMDResMed

$230.03-15% 1Y
Latest close: back above its 200-day averageOct 9, 2026what changed →

What is the market doing?

Mixed

No clear lean: rangebound and insiders net selling (often routine).

3 neutral
TrendRangeboundderived · Oct 9, 2026

Choppy, but holding above its 200-day average. Price is +1% vs its 200-day average.

Insider conviction−$4.2M (90 days to Oct 8, 2026)SEC EDGAR · Oct 8, 2026

Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).

Short interest9.7% of sharesFINRA · Sep 15, 2026

Heavily shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

1-year returnbehind 76% of the market
vs 200-day avgmiddle of the market

Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.

How RMD is trading

ResMed is −15% over the past year while the S&P 500 is +18%: 33 points behind the market.

−15%

1-year return · S&P 500 +18%

vs 200-day average
+1.1%

vs 200-day average · close to trend

RSI (14)
64

RSI (14) · neutral

Below its 52-week high
18%

Below its 52-week high

Sep 17, 2024$182.82 – $291.49 · dashed line: 200-day averageOct 9, 2026
Details›
Last close2026-10-09
$230.03
1 monthS&P 500 +2.7%
+4.7%
1 yearS&P 500 +18%
−15%
5 yearsS&P 500 +88%
−17%
vs 50-day average$224.53
+2.5%
52-week high
$281.12
52-week low
$182.82
Annualised volatility
28%
Calendar-year price return
YearReturn
2026 (year to date)−4.0%
2025+6.3%
2024+34%
2023−17%
2022−19%
2021+23%
2020+38%
2019+38%
2018+36%
2017+39%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan107 of 10+2.7%
Feb104 of 10−0.22%
Mar105 of 10−0.34%
Apr105 of 10−0.51%
May107 of 10+1.7%
Jun109 of 10+6.4%
Jul1110 of 11+6.5%
Aug117 of 11+0.36%
Sep111 of 11−3.1%
Oct115 of 11+0.56%
Nov109 of 10+4.1%
Dec106 of 10−0.54%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.